Example
Warfarin
MoA
Vitamin K epoxide reductase
Inhibitor
Prevents the post-translational gamma-carboxylation of factors II, VII, IX, X
Anticoagulant effect starts when formed active factors are degraded
Indications
Tx: Thromboembolic Disease (DVT/PE) AF Mechanical prosthetic heart valves TIA Rheumatoid Heart Disease
ADR
Bleeding (- Vit K/Prothrombin)
Alopecia
Skin necrosis
Prescribing Advice
Measure the International Normalised Ratio (INR)
= ratio of patient’s PT + control sample
X Liver Disease
X Thyrotoxicosis
X Pregnancy
Decrease w/ antibiotics, Amiodarone, Cimetidine, Clofibrate, Fluconazole, Metronidazole, Antiplatelet drugs, NSAIDs
Increase w/ Barbituates, Carbamazepine, Rifampicin, Sucralfate